Virax Biolabs Group Stock Price on December 4, 2024
| VRAX Stock | USD 1.70 0.11 6.08% |
If you're considering investing in Virax Stock, it is important to understand the factors that can impact its price. As of today, the current price of Virax Biolabs stands at 1.70, as last reported on the 13th of December 2024, with the highest price reaching 1.82 and the lowest price hitting 1.68 during the day. Virax Biolabs Group owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.054, which indicates the firm had a -0.054% return per unit of risk over the last 3 months. Virax Biolabs Group exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Virax Biolabs' Variance of 77.88, coefficient of variation of (1,701), and Risk Adjusted Performance of (0.03) to confirm the risk estimate we provide.
At this time, Virax Biolabs' Total Stockholder Equity is fairly stable compared to the past year. Capital Stock is likely to rise to 2,703 in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 1.4 M in 2024. . At this time, Virax Biolabs' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 0.29 in 2024, whereas Price To Sales Ratio is likely to drop 8.96 in 2024. Virax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Virax |
Sharpe Ratio = -0.054
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VRAX |
Estimated Market Risk
| 8.82 actual daily | 78 78% of assets are less volatile |
Expected Return
| -0.48 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Virax Biolabs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virax Biolabs by adding Virax Biolabs to a well-diversified portfolio.
Price Book 0.8538 | Enterprise Value Ebitda 0.4228 | Price Sales 47.1895 | Shares Float 2.4 M | Wall Street Target Price 20 |
Related Headline
Puma Biotechnology Headline on 4th of December 2024
Puma Biotechnology Reports Inducement Awards Under Nasdaq Li... by businesswire.com
Puma Biotechnology announced the grant of an inducement award to a November new hire, as required under Nasdaq Listing Rule 5635.
Virax Biolabs Valuation on December 4, 2024
It is possible to determine the worth of Virax Biolabs on a given historical date. On December 4, 2024 Virax was worth 1.84 at the beginning of the trading date compared to the closed value of 1.74. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Virax Biolabs stock. Still, in general, we apply an absolute valuation method to find Virax Biolabs' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Virax Biolabs where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Virax Biolabs' related companies.
| Open | High | Low | Close | Volume | |
| 1.92 | 1.98 | 1.82 | 1.86 | 96,001 | |
12/04/2024 | 1.84 | 1.94 | 1.72 | 1.74 | 88,722 |
| 1.74 | 1.82 | 1.69 | 1.71 | 87,094 |
| Backtest Virax Biolabs | | | Virax Biolabs History | | | Virax Biolabs Valuation | Previous | Next |
Virax Biolabs Trading Date Momentum on December 4, 2024
| On December 05 2024 Virax Biolabs Group was traded for 1.71 at the closing time. The top price for the day was 1.82 and the lowest listed price was 1.69 . The trading volume for the day was 87.1 K. The trading history from December 5, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 1.72% . The trading price change against the current closing price is 1.15% . |
Virax Biolabs Group Fundamentals Correlations and Trends
By evaluating Virax Biolabs' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Virax Biolabs' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Virax financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Virax Biolabs Stock history
Virax Biolabs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Virax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Virax Biolabs Group will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Virax Biolabs stock prices may prove useful in developing a viable investing in Virax Biolabs
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2 M | 1.4 M | |
| Net Loss | -4.9 M | -4.7 M |
Virax Biolabs Stock Technical Analysis
Virax Biolabs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Virax Biolabs Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Virax Biolabs Group cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Virax Biolabs December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Virax Biolabs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Virax Biolabs shares will generate the highest return on investment. By undertsting and applying Virax Biolabs stock market strength indicators, traders can identify Virax Biolabs Group entry and exit signals to maximize returns
Virax Biolabs Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Virax Biolabs' price direction in advance. Along with the technical and fundamental analysis of Virax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Virax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (1.77) | |||
| Treynor Ratio | 0.2871 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Virax Stock Analysis
When running Virax Biolabs' price analysis, check to measure Virax Biolabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virax Biolabs is operating at the current time. Most of Virax Biolabs' value examination focuses on studying past and present price action to predict the probability of Virax Biolabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virax Biolabs' price. Additionally, you may evaluate how the addition of Virax Biolabs to your portfolios can decrease your overall portfolio volatility.